|
The Development Advisory Committee oversees creation of fundraising strategies to support the Center’s research projects and programs.
Committee Objectives
- Generate strategic direction and tactics to fund the Center’s dedicated projects (restricted funds) and general activities and projects (unrestricted funds);
- Provide insight regarding the healthcare business environment, motivating factors for giving and sources of potential revenue;
- Offer opinions to assist staff in prioritization of revenue-based initiatives.
R. Michael Bach
Senior Vice President, Sales & Trade Relations
McQueary Bros. Drug Co.
Randolph W. Ballard
Senior Associate Director, Trade
Novartis Pharmaceuticals Corporation
Ann C. Crowder
Senior Account Executive
Procter & Gamble Pharmaceuticals
Rolando DeCardenas
Vice President, General Manager, Oncology Rx
US Oncology Specialty, LP
Richard J. Domann
Segment Vice President, Channel Sales
GlaxoSmithKline
Glenn Esgro
Vice President, Trade
Esprit Pharma
Sidney Geller
Vice President, Specialty Purchasing
Cardinal Health, Inc.
Dawn Gordon
National Account Director
Boehringer Ingelheim Pharmaceuticals, Inc.
Ted D. Lyjak
Director, Trade Sales
Hospira Worldwide, Inc.
Robert E. McHugh
Vice President, Development
New Pharmaceutical Strategies
Staff Liaison:
Karen J. Ribler
Executive Vice President & COO
Center for Healthcare Supply Chain Research
Anti-trust Policy
Anti-harassment Policy
|
